Clevidipine Production Cost Reports

The report provides a detailed analysis essential for establishing a Clevidipine production plant. It encompasses all critical aspects necessary for Clevidipine production, including the cost of Clevidipine production, Clevidipine plant cost, Clevidipine production costs, and the overall Clevidipine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Clevidipine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Clevidipine is a fast-acting calcium channel blocker that is mainly used in hospitals and critical care settings to manage high blood pressure. It is primarily used as an intravenous medication to rapidly control high blood pressure, especially in patients who require short-term and precise blood pressure management.

It works by relaxing the blood vessels, which allows blood to flow more easily and helps to lower blood pressure quickly and safely. It is mainly used during and after surgical procedures, where quick adjustment of blood pressure is necessary to reduce the risk of complications, due to its fast onset. It is generally preferred in intensive care units because it allows easy dose control and quick recovery once the infusion is stopped. It also finds its application in clinical research and drug development focused on cardiovascular therapies that require safe and controllable blood pressure regulation.

The market for Clevidipine is predominantly driven by its application as an ultra-short-acting vasodilator for acute blood pressure management, which promotes its demand in the medical and healthcare sectors. Its application as a calcium channel blocker used for the rapid control of blood pressure in surgical and critical care settings significantly contributes to its demand in the medical and emergency care sectors.

Its demand in emergency situations, including hypertensive crises, due to its fast onset and short duration of action, largely boosts its market growth. Industrial Clevidipine procurement is influenced by various factors, including the cost and secure supply of specialised raw materials, strict production and storage standards, and compliance with healthcare regulations. Moreover, advancements in drug delivery systems, expanding hospital infrastructure, consistent supplier performance, and streamlined pharmaceutical logistics further impact its global market growth.

Raw Material for Clevidipine Production

According to the Clevidipine production plant project report, the major raw materials for Clevidipine production include Methyl 2,3-dichlorobenzylidene Acetoacetate, 2-Cyanoethyl ester of 2-amino-2-propenoic Acid, and Chloromethyl Butyrate.

Production Process of Clevidipine

The extensive Clevidipine production cost report consists of the following industrial production process:

1. Production via Condensation: The production process of Clevidipine begins with the formation of a dihydropyridine core by condensing methyl 2,3-dichlorobenzylidene acetoacetate with the 2-cyanoethyl ester of 2-amino-2-propenoic acid to produce a dihydropyridine diester. Then, the obtained ester is subjected to base-catalysed cleavage to remove the cyanoethyl group and obtain the corresponding monomethyl ester. This intermediate is further esterified with chloromethyl butyrate in the presence of a mild base in refluxing acetonitrile to give Clevidipine as the final product.

Clevidipine is a dihydropyridine calcium channel blocker that appears as a white to off-white solid in its pure form. The compound is formulated commercially as a sterile, milky-white oil-in-water emulsion for intravenous administration. The molecular formula of the compound is C21H23Cl2NO6, and its molecular weight is 456.3 g/mol. The compound has a melting point of approximately 128 to 130 degree Celsius. It is practically insoluble in water but demonstrates good solubility in organic solvents, with a solubility of approximately 91 mg/mL in dimethyl sulfoxide and about 3 mg/mL in ethanol. The compound is photosensitive and must be stored in cartons to protect against photodegradation, with recommended storage at refrigerated temperatures between 2 and 8 degree Celsius. It is a racemic mixture containing two enantiomers with equipotent antihypertensive activity. Clevidipine is contraindicated in patients with allergies to soybeans, soy products, eggs, or egg products, and should be handled with appropriate protective measures.